Voretigene

Trade Name:

Luxturna

Manufacturer/Distributor:

Novartis Pharmaceuticals

Classification:

Cellular and gene therapy

ATC Class:

S01XA27 - voretigene neparvovec

Status:

active

Notice of Compliance (yyyy/mm/dd):

2020/10/13

Date Marketed in Canada (yyyy/mm/dd):

2020/10/13

Presentation:

Subretinal injection: 5 x 10(12) vector genomes/mL. DIN: 02505851

Comments:

For the treatment of adult and pediatric patients with vision loss due to inherited retinal dystrophy.

Keywords:

voretigene

Keywords:

retinal diseases

Access:

public

Back to:

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database

A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)

Generic Name	Common Trade Name(s)	Classification	Date Marketed in Canada (yyyy/mm/dd)
Tobramycin	TOBI Podhaler	Antibiotic	2011/05/02
Tocilizumab	Actemra	Interleukin-6 inhibitor	2010/05/26
Tolvaptan	Samsca	Vasopressin V2 receptor antagonist	2011/09/22
Tolvaptan	Jinarc	Vasopressin V2-receptor antagonist	2015/06/01
Trabectedin	Yondelis	Antineoplastic agent	2010/08/04
Tramadol	Tridural	Analgesic
Tramadol	Zytram XL	Opioid analgesic	2011/03/01
Tramadol	Ultram	Opioid analgesic	2010/05/01
Tramadol	Durela	Narcotic	2012/03/19
Trastuzumab deruxtecan	Enhertu	Antineoplastic agent	2021/04/15
Trastuzumab emtansine	Kadcyla	Antineoplastic agent	2013/09/27
Trazodone	Desyrel	Antidepressant	2010/05/14
Triprolidine + codeine + pseudoephedrine + guaifenesin	CoACTIFED Expectorant	Antitussive	2012/11/26
Tucatinib	Tukysa	Antineoplastic agent	2020/10/08
Ulipristal	Fibristal	Selective progesterone receptor modulator (SERM)
Ulipristal acetate	Fibristal	Selective progesterone receptor modulator	2013/07/23
Ulipristal acetate	Ella	Contraceptive	2015/09/01
Upadacitinib	Rinvoq	Disease-modifying antirheumatic agent	2020/01/16
Vandetanib	Caprelsa	Receptor tyrosine kinase inhibitor (antineoplastic agent)	2012/01/24
Vardenafil	Staxyn	Phosphodiesterase Type 5 Inhibitor	2011/08/29
Varenicline	Champix	Smoking cessation aid	2007/04
Vedolizumab	Entyvio	Immunosuppressive agent	2015/04/21
Velaglucerase alfa	Vpriv	Enzyme replacement for treatment of Gaucher disease	2010/11/22
Vemurafenib	Zelboraf	Protein kinase inhibitor	2012/03/06
Vemurafenib	Zelboraf	Antineoplastic agent	2012/02
Venetoclax	Venclexta	Antineoplastic agent	2016/10/31
Vilazodone	Viibryd	Antidepressant	2015/07/16
Vitamin C	Prevegyne	Gynecological antiinfectives and antiseptics	2011/01
Voretigene	Luxturna	Cellular and gene therapy	2020/10/13
Vorinostat	Zolinza	Histone deacetylase inhibitor, anti-neoplastic agent	2009/06/17
Vortioxetine	Trintellix	Antidepressant	2014/10/28
Warfarin	Coumadin	Anticoagulant	2020/04/23
White birch extract (Betula verrucosa)	Itulatek	Allergy immunotherapy	2020/09/28
Zafirlukast	Accolate	Leukotriene modifier for asthma
Zolpidem	Sublinox	Hypnotic	2011-12-07
Zoster vaccine	Zostavax	Vaccine	2009/08/11